Barbara Seliger
Hat mitgewirkt an:
-
Tumor immunology meets oncology (TIMO) XVII, April 20–22 2023 in Halle/Saale, Germany
-
Comparative expression profiling for human endoplasmic reticulum-resident aminopeptidases 1 and 2 in normal kidney versus distinct renal cell carcinoma subtypes
-
Evaluation of TCR amplification in tumor lesions and peripheral blood of renal cell carcinoma patients
-
Epigenetic control of the ubiquitin carboxyl terminal hydrolase 1 in renal cell carcinoma